Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair

ClinicalTrials.gov ID: NCT03262688

Public ClinicalTrials.gov record NCT03262688. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Analgesic Effect of the INL-001 Bupivacaine Hydrochloride (HCl) Collagen-Matrix Implant in Children 2 to <17 Years of Age Following Open Inguinal Hernia Repair

Study identification

NCT ID
NCT03262688
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Innocoll
Industry
Enrollment
159 participants

Conditions and interventions

Interventions

  • Bupivacaine HCl collagen-matrix implant Drug
  • Bupivacaine HCl infiltration Drug

Drug

Eligibility (public fields only)

Age range
2 Years to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 15, 2017
Primary completion
Jan 30, 2024
Completion
Jan 30, 2024
Last update posted
Jul 29, 2021

2017 – 2024

United States locations

U.S. sites
11
U.S. states
5
U.S. cities
9
Facility City State ZIP Site status
Alliance Research Centers Laguna Hills California 92653 Recruiting
Cornerstone Research Institute Altamonte Springs Florida 32701 Recruiting
Medical Research Center Miami Florida 33144 Withdrawn
Elion & Volhard Pharmaceutical Research (E&V PR) Miami Florida 33165 Withdrawn
Children's Hospital of Pittsburgh of UPMC (CHP-UPMC) Pittsburgh Pennsylvania 15224 Recruiting
Driscoll Children's Hospital Corpus Christi Texas 78411 Recruiting
El Paso Children's Hospital El Paso Texas 79905 Recruiting
Memorial Hermann Memorial City Medical Center Houston Texas 77024 Recruiting
The Woman's Hospital of Texas Houston Texas 77054 Withdrawn
Plano Surgical Hospital Plano Texas 75093 Recruiting
Jean Brown Research Salt Lake City Utah 84124 Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03262688, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03262688 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →